Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project (R01)
Project #
5R01HL035246-11
Application #
2217767
Study Section
Hematology Subcommittee 2 (HEM)
Project Start
1985-12-01
Project End
1999-05-31
Budget Start
1996-06-01
Budget End
1997-05-31
Support Year
11
Fiscal Year
1996
Total Cost
Indirect Cost
Name
University of New Mexico
Department
Pathology
Type
Schools of Medicine
DUNS #
829868723
City
Albuquerque
State
NM
Country
United States
Zip Code
87131
Kamei, S; Kazama, Y; Kuijper, J L et al. (2001) Genomic structure and promoter activity of the human tissue factor pathway inhibitor-2 gene. Biochim Biophys Acta 1517:430-5
Arepally, G M; Kamei, S; Park, K S et al. (2000) Characterization of a murine monoclonal antibody that mimics heparin-induced thrombocytopenia antibodies. Blood 95:1533-40
Kazama, Y; Kamei, S; Kuijper, J L et al. (2000) Nucleotide sequence of the gene encoding murine tissue factor pathway inhibitor-2. Thromb Haemost 83:141-7
Neaud, V; Hisaka, T; Monvoisin, A et al. (2000) Paradoxical pro-invasive effect of the serine proteinase inhibitor tissue factor pathway inhibitor-2 on human hepatocellular carcinoma cells. J Biol Chem 275:35565-9
Dahlen, J R; Foster, D C; Kisiel, W (1999) Inhibition of neutrophil elastase by recombinant human proteinase inhibitor 9. Biochim Biophys Acta 1451:233-41
Annand, R R; Dahlen, J R; Sprecher, C A et al. (1999) Caspase-1 (interleukin-1beta-converting enzyme) is inhibited by the human serpin analogue proteinase inhibitor 9. Biochem J 342 Pt 3:655-65
Bajaj, M S; Steer, S; Kuppuswamy, M N et al. (1999) Synthesis and expression of tissue factor pathway inhibitor by serum-stimulated fibroblasts, vascular smooth muscle cells and cardiac myocytes. Thromb Haemost 82:1663-72
Kamei, S; Petersen, L C; Sprecher, C A et al. (1999) Inhibitory properties of human recombinant Arg24-->Gln type-2 tissue factor pathway inhibitor (R24Q TFPI-2). Thromb Res 94:147-52
Hamamoto, T; Kisiel, W (1998) The effect of cell surface glycosaminoglycans (GAGs) on the inactivation of factor VIIa--tissue factor activity by antithrombin III. Int J Hematol 68:67-78
Yan, S F; Zou, Y S; Gao, Y et al. (1998) Tissue factor transcription driven by Egr-1 is a critical mechanism of murine pulmonary fibrin deposition in hypoxia. Proc Natl Acad Sci U S A 95:8298-303

Showing the most recent 10 out of 83 publications